These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32172400)

  • 1. Transplantation of IFN-γ Primed hUCMSCs Significantly Improved Outcomes of Experimental Autoimmune Encephalomyelitis in a Mouse Model.
    Zhou X; Liu X; Liu L; Han C; Xie Z; Liu X; Xu Y; Li F; Bi J; Zheng C
    Neurochem Res; 2020 Jul; 45(7):1510-1517. PubMed ID: 32172400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-γ-Primed hUCMSCs Significantly Reduced Inflammation
    Ling X; Wang T; Han C; Wang P; Liu X; Zheng C; Bi J; Zhou X
    Front Immunol; 2022; 13():835345. PubMed ID: 35300342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetramethylpyrazine enhanced the therapeutic effects of human umbilical cord mesenchymal stem cells in experimental autoimmune encephalomyelitis mice through Nrf2/HO-1 signaling pathway.
    Zhang L; Wang X; Lu X; Ma Y; Xin X; Xu X; Wang S; Hou Y
    Stem Cell Res Ther; 2020 May; 11(1):186. PubMed ID: 32430010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis.
    Wang D; Li SP; Fu JS; Bai L; Guo L
    Int J Dev Neurosci; 2016 Apr; 49():60-6. PubMed ID: 26827767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of transplanted human Wharton's jelly mesenchymal stem cells treated with IFN-γ on experimental autoimmune encephalomyelitis mice.
    Torkaman M; Ghollasi M; Mohammadnia-Afrouzi M; Salimi A; Amari A
    Cell Immunol; 2017 Jan; 311():1-12. PubMed ID: 27697286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic Effect of SPK1 Gene Transfected Adipose Derived Mesenchymal Stem Cells on Experimental Autoimmune Encephalomyelitis Mice and Its Effect on T Helper Cell 17/Regulatory T Cells Balance].
    Zhou T; Xu CP; Xiao Y; Zhang Q; Li L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Dec; 42(6):755-765. PubMed ID: 33423722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of locomotor function and microscopic structure of the spinal cord in a mouse model of experimental autoimmune encephalomyelitis following treatment with syngeneic mesenchymal stem cells.
    Mitra NK; Bindal U; Eng Hwa W; Chua CL; Tan CY
    Int J Clin Exp Pathol; 2015; 8(10):12041-52. PubMed ID: 26722389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal injection of mesenchymal stem cells-conditioned media (MSCS-CM) treated monocyte can potentially alleviate motor defects in experimental autoimmune encephalomyelitis female mice; An original experimental study.
    Jalali Kondori B; Abdolmaleki A; Raei M; Ghorbani Alvanegh A; Esmaeili Gouvarchin Ghaleh H
    Transpl Immunol; 2024 Aug; 85():102067. PubMed ID: 38839021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice.
    Hou Y; Ryu CH; Park KY; Kim SM; Jeong CH; Jeun SS
    Stem Cell Res Ther; 2013 Jul; 4(4):77. PubMed ID: 23826999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles attenuate experimental autoimmune encephalomyelitis via regulating pro and anti-inflammatory cytokines.
    Ahmadvand Koohsari S; Absalan A; Azadi D
    Sci Rep; 2021 Jun; 11(1):11658. PubMed ID: 34079033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the role of mesenchymal stem cells in modulating immune responses via Treg and Th2 cell activation: insights from mouse model of multiple sclerosis.
    Sadeghnejad A; Pazoki A; Yazdanpanah E; Esmaeili SA; Yousefi B; Sadighi-Moghaddam B; Baharlou R; Haghmorad D
    APMIS; 2024 Nov; 132(11):888-899. PubMed ID: 39030955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of AD-MSC (adipose-derived mesenchymal stem cells) as a vehicle for IFN-β delivery in experimental autoimmune encephalomyelitis.
    Mohammadzadeh A; Pourfathollah AA; Shahrokhi S; Fallah A; Tahoori MT; Amari A; Forouzandeh M; Soleimani M
    Clin Immunol; 2016 Aug; 169():98-106. PubMed ID: 27373971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
    Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
    Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis.
    Yu JW; Li YH; Song GB; Yu JZ; Liu CY; Liu JC; Zhang HF; Yang WF; Wang Q; Yan YP; Xiao BG; Ma CG
    J Mol Neurosci; 2016 Dec; 60(4):486-497. PubMed ID: 27573128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
    Togha M; Jahanshahi M; Alizadeh L; Jahromi SR; Vakilzadeh G; Alipour B; Gorji A; Ghaemi A
    Mol Neurobiol; 2017 May; 54(4):2445-2457. PubMed ID: 26971291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis.
    Rafei M; Birman E; Forner K; Galipeau J
    Mol Ther; 2009 Oct; 17(10):1799-803. PubMed ID: 19602999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human mesenchymal stem cells upregulate CD1dCD5(+) regulatory B cells in experimental autoimmune encephalomyelitis.
    Guo Y; Chan KH; Lai WH; Siu CW; Kwan SC; Tse HF; Wing-Lok Ho P; Wing-Man Ho J
    Neuroimmunomodulation; 2013; 20(5):294-303. PubMed ID: 23899693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CC chemokine receptor 5 antagonist alleviates inflammation by regulating IFN-γ/IL-10 and STAT4/Smad3 signaling in a mouse model of autoimmune encephalomyelitis.
    Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Shahid M; Al-Mazroua HA; As Sobeai HM; Alasmari AF; Alanazi MM; Alhamed AS; Aldossari AA; Attia SM
    Cell Immunol; 2022 Sep; 379():104580. PubMed ID: 35872534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-γ-Treated Mesenchymal Stem Cells Modulate the T Cell-Related Chemokines and Chemokine Receptors in an Animal Model of Experimental Autoimmune Encephalomyelitis.
    Ahmadifard R; Jafarzadeh A; Mahmoodi M; Nemati M; Rahmani M; Khorramdelazad H; Ayoobi F
    Drug Res (Stuttg); 2023 Apr; 73(4):213-223. PubMed ID: 36754055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE).
    Yousefi F; Ebtekar M; Soleimani M; Soudi S; Hashemi SM
    Int Immunopharmacol; 2013 Nov; 17(3):608-16. PubMed ID: 23973288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.